.png){kind=icon}
返回
General dermatology
.png){kind=icon}
PRE
AI
DOI：10.1093/ced/llaf091.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Human leucocyte antigen (HLA) testing can be carried out to identify patients who are at risk of severe cutaneous reactions to carbamazepine. This article asks the question of readers: if positive, which of the HLA alleles would suggest a risk of drug reaction with eosinophilia and systemic symptoms (DRESS) with carbamazepine use?
